China develops nanomaterial to combat COVID-19: Report

A team of Chinese scientists has reportedly developed a novel way to combat the new coronavirus that causes the Covid-19 disease which has killed over 32,000 people globally.

According to Global Times, the new weapon is not a drug or a compound but some nanomaterial.

“Chinese scientists have developed a new weapon to combat the #coronavirus,” the news portal tweeted on Sunday.

“They say they have found a nanomaterial that can absorb and deactivate the virus with 96.5-99.9 per cent efficiency,” it added.

Nanomaterials are used in a variety of manufacturing processes, products and healthcare including paints, filters, insulation and lubricant additives.

In healthcare, Nanozymes are nanomaterials with enzyme-like characteristics.

According to the US NIH, scientists have not unanimously settled on a precise definition of nanomaterials, but agree that they are partially characterized by their tiny size, measured in nanometers.

“Nanotechnology can be used to design pharmaceuticals that can target specific organs or cells in the body such as cancer cells, and enhance the effectiveness of therapy,” said NIH.

However, while engineered nanomaterials provide great benefits, “we know very little about the potential effects on human health and the environment. Even well-known materials, such as silver for example, may pose a hazard when engineered to nano size,” according to NIH.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre

    US FDA launches expedited IND Pilot, begins accepting applications

    US FDA launches expedited IND Pilot, begins accepting applications

    PIL in SC seeks time-bound probe, stringent action against fake drug networks

    PIL in SC seeks time-bound probe, stringent action against fake drug networks

    Ghaziabad: Fake supplement racket busted, 5 held

    Ghaziabad: Fake supplement racket busted, 5 held

    22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

    22 medical stores raided in Hisar, 7 stocked dual-use drugs without records